Duearity (English Wikipedia)

Grewal R, Spielmann PM, Jones SE, Hussain SS (December 2014). "Clinical efficacy of tinnitus retraining therapy and cognitive behavioural therapy in the treatment of subjective tinnitus: a systematic review". J Laryngol Otol. 128 (12): 1028–33. doi:10.1017/S0022215114002849. PMID 25417546. S2CID 42092743.
Bauer CA, Berry JL, Brozoski TJ (August 2017). "The effect of tinnitus retraining therapy on chronic tinnitus: A controlled trial". Laryngoscope Investig Otolaryngol. 2 (4): 166–177. doi:10.1002/lio2.76. PMC 5562945. PMID 28894836.
Herraiz C, Hernandez FJ, Toledano A, Aparicio JM (2007). "Tinnitus retraining therapy: prognosis factors". Am J Otolaryngol. 28 (4): 225–9. doi:10.1016/j.amjoto.2006.09.004. PMID 17606035.
Han M, Yang X, Lv J (2021). "Efficacy of tinnitus retraining therapy in the treatment of tinnitus: A meta-analysis and systematic review". Am J Otolaryngol. 42 (6): 103151. doi:10.1016/j.amjoto.2021.103151. PMID 34303210.

duearity.com

ir.duearity.com

"Duearity AB (publ) i konkurs". Duearity (in Swedish). 23 September 2024. Archived from the original on 27 September 2024. Retrieved 27 September 2024.

fda.gov

accessdata.fda.gov

"510(k) Notification". Food and Drug Administration – accessdata.fda.gov. 1 November 2002. Archived from the original on 24 May 2024. Retrieved 24 May 2024.
"510(k) Summary" (PDF). accessdata.fda.gov. 24 May 2024. Archived from the original (PDF) on 24 May 2024. Retrieved 24 May 2024.

healthtechdigital.com

Digital Health Technology News: Swedish MedTech startup starts pre-sale of unique product for tinnitus treatment - Digital Health Technology News Archived 9 February 2022 at the Wayback Machine, accessdate: 6 december 2022

medtechmagazine.se

MedTech Magazine: Cochlearity blir Duearity inför börsnotering - MedTech Magazine Archived 15 December 2022 at the Wayback Machine, accessdate: 6 december 2022
Göransson, Anders (11 September 2024). "Tidigare börsraketen i konkurs – "Fortsatt drift inte möjlig"". Medtech Magazine (in Swedish). Archived from the original on 27 September 2024. Retrieved 27 September 2024.
MedTech Magazine: Malmöbolag lanserar produkt för egenbehandling av tinnitus - MedTech Magazine Archived 15 December 2022 at the Wayback Machine, accessdate: 6 december 2022
MedTech Magazine: Cochlearity blir Duearity inför börsnotering - MedTech Magazine Archived 15 December 2022 at the Wayback Machine, accessdate: 6 december 2022

mfn.se

storage.mfn.se

Annual Report 2021: arsredovisning-2021-duearity-ab-signerad.pdf Archived 10 December 2022 at the Wayback Machine, accessdate: 6 december 2022
"Duearity 2022 Q3" (PDF). MFN (in Swedish). Retrieved 15 December 2022.

nasdaq.com

view.news.eu.nasdaq.com

"Delisting of Duearity AB (publ) from Nasdaq First North Growth Market". Nasdaq. 10 September 2024. Archived from the original on 27 September 2024. Retrieved 27 September 2024.
"Duearity AB:s halvårsrapport för perioden 1 januari till 30 juni 2021". Nasdaq News (in Swedish). 25 August 2021. Retrieved 15 December 2022.
PRV avser att godkänna Duearitys patentansökan: PRV avser att godkänna Duearitys patentansökan Archived 15 December 2022 at the Wayback Machine, accessdate: 6 december 2022

nasdaq.com

Nasdaq: Listing of Duearity AB (publ), on Nasdaq First North Growth Market (203/21) | Nasdaq, accessdate: 6 december 2022

nasdaqomxnordic.com

Nasdaq: DEAR, Duearity, (SE0015949482) - Nasdaq Archived 15 December 2022 at the Wayback Machine, accessdate: 6 december 2022

nih.gov

pubmed.ncbi.nlm.nih.gov

Grewal R, Spielmann PM, Jones SE, Hussain SS (December 2014). "Clinical efficacy of tinnitus retraining therapy and cognitive behavioural therapy in the treatment of subjective tinnitus: a systematic review". J Laryngol Otol. 128 (12): 1028–33. doi:10.1017/S0022215114002849. PMID 25417546. S2CID 42092743.
Bauer CA, Berry JL, Brozoski TJ (August 2017). "The effect of tinnitus retraining therapy on chronic tinnitus: A controlled trial". Laryngoscope Investig Otolaryngol. 2 (4): 166–177. doi:10.1002/lio2.76. PMC 5562945. PMID 28894836.
Herraiz C, Hernandez FJ, Toledano A, Aparicio JM (2007). "Tinnitus retraining therapy: prognosis factors". Am J Otolaryngol. 28 (4): 225–9. doi:10.1016/j.amjoto.2006.09.004. PMID 17606035.
Han M, Yang X, Lv J (2021). "Efficacy of tinnitus retraining therapy in the treatment of tinnitus: A meta-analysis and systematic review". Am J Otolaryngol. 42 (6): 103151. doi:10.1016/j.amjoto.2021.103151. PMID 34303210.

ncbi.nlm.nih.gov

Bauer CA, Berry JL, Brozoski TJ (August 2017). "The effect of tinnitus retraining therapy on chronic tinnitus: A controlled trial". Laryngoscope Investig Otolaryngol. 2 (4): 166–177. doi:10.1002/lio2.76. PMC 5562945. PMID 28894836.

omniekonomi.se

Hörselbolaget Duearity till First North: Hörselbolaget Duearity till First North Archived 1 December 2022 at the Wayback Machine, accessdate: 6 december 2022

prv.se

tc.prv.se

Svensk Patentdatabas, Träfflista: Svensk Patentdatabas, Träfflista Archived 15 December 2022 at the Wayback Machine, accessdate: 6 december 2022
"Swedish Patent Database, Results list". Swedish Patent Database. 27 July 2020. Retrieved 14 December 2022.

semanticscholar.org

api.semanticscholar.org

Grewal R, Spielmann PM, Jones SE, Hussain SS (December 2014). "Clinical efficacy of tinnitus retraining therapy and cognitive behavioural therapy in the treatment of subjective tinnitus: a systematic review". J Laryngol Otol. 128 (12): 1028–33. doi:10.1017/S0022215114002849. PMID 25417546. S2CID 42092743.

skatteverket.se

Skatteverket: Duearity AB | Skatteverket Archived 15 December 2022 at the Wayback Machine, accessdate: 6 december 2022
"Duearity". Skatteverket (in Swedish). 11 May 2021. Archived from the original on 27 September 2024. Retrieved 27 September 2024.

web.archive.org

"Duearity AB (publ) i konkurs". Duearity (in Swedish). 23 September 2024. Archived from the original on 27 September 2024. Retrieved 27 September 2024.
"First North-listade Duearity handelsstoppad – ska ansöka om konkurs". Dagens industri (in Swedish). 6 September 2024. Archived from the original on 11 September 2024. Retrieved 27 September 2024.
Annual Report 2021: arsredovisning-2021-duearity-ab-signerad.pdf Archived 10 December 2022 at the Wayback Machine, accessdate: 6 december 2022
MedTech Magazine: Cochlearity blir Duearity inför börsnotering - MedTech Magazine Archived 15 December 2022 at the Wayback Machine, accessdate: 6 december 2022
Nasdaq: DEAR, Duearity, (SE0015949482) - Nasdaq Archived 15 December 2022 at the Wayback Machine, accessdate: 6 december 2022
Skatteverket: Duearity AB | Skatteverket Archived 15 December 2022 at the Wayback Machine, accessdate: 6 december 2022
The Wall Street Journal: Duearity DEAR.SE | Duearity AB Financial Statements - WSJ Archived 15 December 2022 at the Wayback Machine, accessdate: 6 december 2022
"Delisting of Duearity AB (publ) from Nasdaq First North Growth Market". Nasdaq. 10 September 2024. Archived from the original on 27 September 2024. Retrieved 27 September 2024.
Göransson, Anders (11 September 2024). "Tidigare börsraketen i konkurs – "Fortsatt drift inte möjlig"". Medtech Magazine (in Swedish). Archived from the original on 27 September 2024. Retrieved 27 September 2024.
Gisborn, Linus (13 September 2024). "VD:ns hårda ord efter konkursen: "Förväxta bebisinvesterare"". Affärsvärlden (in Swedish). Archived from the original on 27 September 2024. Retrieved 27 September 2024.
"Duearity". Skatteverket (in Swedish). 11 May 2021. Archived from the original on 27 September 2024. Retrieved 27 September 2024.
Hörselbolaget Duearity till First North: Hörselbolaget Duearity till First North Archived 1 December 2022 at the Wayback Machine, accessdate: 6 december 2022
Affärsvärlden: Duearity - IPO | Affärsvärlden Archived 25 January 2022 at the Wayback Machine, accessdate: 6 december 2022
Digital Health Technology News: Swedish MedTech startup starts pre-sale of unique product for tinnitus treatment - Digital Health Technology News Archived 9 February 2022 at the Wayback Machine, accessdate: 6 december 2022
MedTech Magazine: Malmöbolag lanserar produkt för egenbehandling av tinnitus - MedTech Magazine Archived 15 December 2022 at the Wayback Machine, accessdate: 6 december 2022
MedTech Magazine: Cochlearity blir Duearity inför börsnotering - MedTech Magazine Archived 15 December 2022 at the Wayback Machine, accessdate: 6 december 2022
BioStock: Duearity vill hjälpa personer med tinnitusbesvär - BioStock Archived 15 December 2022 at the Wayback Machine, accessdate: 6 december 2022
Duearity ska noteras på Nasdaq First North den 11 maj: Duearity ska noteras på Nasdaq First North den 11 maj Archived 9 May 2021 at the Wayback Machine, accessdate: 6 december 2022
Svensk Patentdatabas, Träfflista: Svensk Patentdatabas, Träfflista Archived 15 December 2022 at the Wayback Machine, accessdate: 6 december 2022
PRV avser att godkänna Duearitys patentansökan: PRV avser att godkänna Duearitys patentansökan Archived 15 December 2022 at the Wayback Machine, accessdate: 6 december 2022
"510(k) Notification". Food and Drug Administration – accessdata.fda.gov. 1 November 2002. Archived from the original on 24 May 2024. Retrieved 24 May 2024.
"510(k) Summary" (PDF). accessdata.fda.gov. 24 May 2024. Archived from the original (PDF) on 24 May 2024. Retrieved 24 May 2024.

wsj.com

The Wall Street Journal: Duearity DEAR.SE | Duearity AB Financial Statements - WSJ Archived 15 December 2022 at the Wayback Machine, accessdate: 6 december 2022